Hebe Aesthetics and Vitality

Hebe Aesthetics and Vitality operates as a medical wellness boutique in Atlanta, Georgia, under the medical direction of Dr. Eric Chang. The clinic concentrates on peptide-based weight management protocols and aesthetic medicine, serving patients throughout the Atlanta metropolitan area who seek physician-supervised approaches to metabolic health and age management. The practice model combines medical weight loss with aesthetic procedures, allowing patients to address body composition and appearance concerns within a single clinical setting.

The clinic's weight loss programs center on two GLP-1 receptor agonist peptides: semaglutide and tirzepatide. Semaglutide therapy at Hebe Aesthetics involves weekly subcutaneous injections that work by mimicking the incretin hormone GLP-1, which regulates appetite and glucose metabolism. Tirzepatide represents a dual-action peptide that activates both GIP and GLP-1 receptors, offering an alternative mechanism for patients who require enhanced metabolic support. Both peptide protocols include baseline metabolic assessments, dosage titration schedules, and monitoring for side effects such as nausea or gastrointestinal changes. The clinic structures these programs with regular follow-up appointments to adjust dosing based on individual response and weight loss trajectory. Beyond peptide injections, the practice offers complementary aesthetic services including botulinum toxin injections for dynamic wrinkles, chemical peels for skin resurfacing, and intravenous nutrient therapy with multivitamin formulations designed to support patients during caloric restriction phases.

Dr. Eric Chang serves as Medical Director, providing clinical oversight for all peptide therapy protocols and aesthetic procedures performed at the Atlanta location. The clinic employs nurse practitioners who conduct initial consultations, perform physical assessments, and administer injections under Dr. Chang's supervision. These nurse practitioners field patient questions about treatment expectations, potential side effects, and lifestyle modifications that enhance peptide therapy outcomes. The clinical team reviews each patient's medical history to identify contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, which preclude GLP-1 agonist use. Patients with previous bariatric procedures, significant gastrointestinal disease, or concurrent use of other weight loss medications receive individualized protocol modifications.

Patients at Hebe Aesthetics and Vitality attend in-person consultations at the Atlanta clinic, where they complete intake paperwork detailing current medications, weight history, and health goals. The initial visit includes body composition analysis, discussion of realistic weight loss timelines, and education about injection technique for patients who will self-administer at home. Follow-up appointments occur every four to six weeks during the titration phase, then extend to longer intervals once patients reach maintenance dosing. The clinic provides patients with injection supplies, sharps containers, and written instructions for proper peptide storage and administration. Patients report their experiences through the clinic's communication channels, allowing the clinical team to adjust treatment plans between scheduled visits. The practice addresses aesthetic concerns that emerge during weight loss, such as volume loss in the face, by offering concurrent treatments like dermal fillers or skin tightening procedures.

Hebe Aesthetics and Vitality differentiates itself in the Atlanta medical weight loss market through its integration of peptide therapy with aesthetic medicine, allowing patients to manage both metabolic and cosmetic aspects of aging within one practice. The clinic's 5.0-star rating across 50 Google reviews reflects patient feedback on the nurse practitioners' responsiveness to questions, the thoroughness of treatment explanations, and the clinical team's willingness to customize protocols. The practice does not offer telehealth consultations, requiring all patients to visit the Atlanta location for assessments and treatment initiation. This in-person model enables the clinical team to perform hands-on evaluations, demonstrate proper injection technique, and monitor patients for adverse reactions during the initial treatment phases. The clinic's focus on GLP-1 and dual incretin agonists positions it specifically for patients seeking pharmaceutical-grade peptide interventions rather than broader functional medicine approaches, making it a targeted option for Atlanta residents prioritizing evidence-based weight management with aesthetic support services.